BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 21, 2008
View Archived Issues
Extended-release hydrocodone/acetaminophen improves pain, function in osteoarthritis patients
Read More
SAR-113945 shows potential for osteoarthritic joint pain
Read More
Novel CB1 receptor antagonist profiled at Bristol-Myers Squibb
Read More
Telik enters into diabetes license agreement with ReceptorBio
Read More
Vertex initiates phase III REALIZE trial with telaprevir in HCV
Read More
Vion plans to conduct a phase III trial of Cloretazine in combination with AML and MDS therapy
Read More
Recent patent literature divulges novel treatment options for diabetes
Read More
New compounds for pulmonary hypertension reported in recent Concert patent
Read More
New treatments for autoimmune disorders disclosed in recent patents
Read More
4SC describes new compounds for urinary incontinence in recent patent
Read More
sc28AT potentiates tacrolimus effect on acute kidney allograft rejection in baboons
Read More
TY-027: a novel approach to treating neuropathic pain
Read More
Melior collaborates with AstraZeneca using theraTRACE discovery platform
Read More
Boehringer Ingelheim and Ablynx extend research collaboration in AD
Read More
Lilly completes acquisition of SGX
Read More
Noven enters license agreement with Procter & Gamble for HSDD patches
Read More
RegeneRx completes patient enrollment in phase II RGN-137 trial
Read More
Activx reports topline results from phase Ib and phase IIa clinical trials of KRP-1
Read More
EMEA accepts for review Arpida's MAA for intravenous iclaprim in cSSTI
Read More
Enobia begins testing of enzyme replacement therapy for hypophosphatasia
Read More
Dual P2X3/P2X2/3 purinergic receptor antagonists profiled at Roche
Read More
NovaRx initiates pivotal phase III trial for Lucanix in lung cancer
Read More